UPDATE 1-Bristol wins EU green light for immune system cancer drug

April 24, 2015 11:58 AM

13 0

LONDON, April 24 (Reuters) - European regulators have recommended approval of Bristol-Myers Squibb's Opdivo, paving the way for it to become the first of a closely watched group of immune system-boosting cancer medicines to go on sale in Europe.

The drug, also known as nivolumab, was given a green light on Friday by the European Medicines Agency (EMA) for the treatment of melanoma. It is already approved in the United States for melanoma and lung cancer.

Read more

To category page